翔安生醫

 Acusense BioMedical Technology Co., Ltd.

Founded in 2017,  we are committed to developing innovative medical solutions using cutting-edge Artificial Intelligence (AI) and Internet of Things (IoT) technologies. Our core goal is to improve clinical efficiency, patient safety, and overall healthcare quality.

AcuSense BioMedical Technology Co., Ltd. was established in 2017 and is committed to developing innovative medical solutions using cutting-edge artificial intelligence (AI) and Internet of Things (IoT) technologies. Our core goal is to improve clinical efficiency, patient safety and overall healthcare quality.

2023.03

Selected by Czech Accelerator Caelestinus Healthtech Incubator

2022.11

Attended the MEDICA in Düsseldorf, Germany and the medical device industry visit in Prague, Czech Republic

2022.09

Passed the NSTC x MEDICA 2022 selection

2021.12

Shortlisted in the top ten of Qualcomm Taiwan Innovation Competition

2021.08

Tainan Municipal Annan Hospital clinical trial approved [IRB number: TMANHIIO· C024]

2021.07

Shortlisted for the 9th Clouded Leopard Training Program, and worked with Lingqun Computer

2021.05

3rd IEEE ECBIOS 2021 Best Conference Paper (two papers)

2021.01

Selected as TAcc Propel Accelerator Team by the SME Department

2020.06

European Association of Nephrology (ERA-EDTA 2020) clinical research results published

2020.04

MIT COVID-19 Hackathon challenge potential proposal

2020.04

Launched overseas strategic alliance with Hugui Xingye × Zhengmei Group

2020.02

BE Accelerator selected team

2019.12

The 16th National Innovation Award

2019.11

Excellent Works of the "AI Smart Application New Generation Talent Training Program" by the Industrial Development Bureau, Ministry of Economic Affairs